Cargando…
Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis
HER2/ERBB2 amplification/overexpression determines the eligibility of breast cancer patients to HER2-targeted therapy. This study evaluates the agreement between ERBB2 copy number assessment by fluorescence in situ hybridization, a standard method recommended by the American Society of Clinical Onco...
Autores principales: | Christgen, Matthias, van Luttikhuizen, Jana L., Raap, Mieke, Braubach, Peter, Schmidt, Lars, Jonigk, Danny, Feuerhake, Friedrich, Lehmann, Ulrich, Schlegelberger, Brigitte, Kreipe, Hans H., Steinemann, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347728/ https://www.ncbi.nlm.nih.gov/pubmed/27716627 http://dx.doi.org/10.18632/oncotarget.12421 |
Ejemplares similares
-
Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinoma
por: Christgen, Matthias, et al.
Publicado: (2017) -
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer
por: Grote, Isabel, et al.
Publicado: (2022) -
High frequency of lobular breast cancer in distant metastases to the orbit
por: Raap, Mieke, et al.
Publicado: (2015) -
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
por: Christgen, Matthias, et al.
Publicado: (2020) -
Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast
por: Radner, Martin, et al.
Publicado: (2020)